Literature DB >> 22623643

Restless legs syndrome.

Guy Leschziner1, Paul Gringras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22623643     DOI： 10.1136/bmj.e3056

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3.

Authors:  Shi-Rui Gan; Karla P Figueroa; Hao-Ling Xu; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Liana Rosenthal; Tetsuo Ashizawa; Stefan M Pulst; Ning Wang; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2020-02-17       Impact factor: 4.891

Review 2.  Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Authors:  Michele A Faulkner
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

Review 3.  Gabapentin enacarbil: in patients with restless legs syndrome.

Authors:  Lesley J Scott
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

4.  The effect of vibration on the severity of restless legs syndrome in hemodialysis patients.

Authors:  Habibollah Hosseini; Majid Kazemi; Somayeh Azimpour
Journal:  J Renal Inj Prev       Date:  2016-11-21

5.  Premenopausal Women With a Diagnosis of Endometriosis Have a Significantly Higher Prevalence of a Diagnosis or Symptoms Suggestive of Restless Leg Syndrome: A Prospective Cross-Sectional Questionnaire Study.

Authors:  Nicola Tempest; Madeleine Boyers; Alice Carter; Steven Lane; Dharani K Hapangama
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

6.  Characteristics of Objective Sleep and Its Related Risk Factors Among Parkinson's Disease Patients With and Without Restless Legs Syndrome.

Authors:  Shuyu Sun; Xianchao Zhao; Jiafeng Ren; Jinxiang Cheng; Junying Zhou; Changjun Su
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.